Journal: Therapeutic innovation & regulatory science
This publication outlines a practical framework to improve inclusion of under-represented women—specifically Black women with breast cancer—in clinical research.
Core points:
- Problem defined: Despite advances in breast cancer treatment and outcomes, women who are disproportionately affected—particularly Black women—remain under-represented in clinical studies, limiting the generalizability and equity of research findings.
- Framework focus:
- Identifies structural and systemic barriers that impede participation of Black women in trials.
- Emphasizes the need to intentionally design studies that address these barriers rather than treating under-representation as an incidental issue.
- Key determinants of recruitment and retention:
- Incorporates patient perspectives on trust, communication, cultural relevance, logistical barriers (e.g., time, transportation), and perceived value of participation.
- Stresses bidirectional engagement with communities and tailoring outreach and consent processes to patient needs.
- Broader applicability:
- Positions the framework as a model that can be adapted to other therapeutic areas to:
- Improve representativeness of study populations,
- Enhance patient engagement, and
- Inform more equitable and inclusive study design and conduct.
- Positions the framework as a model that can be adapted to other therapeutic areas to:
The piece is essentially a guidance-oriented report aimed at operationalizing equity in clinical research participation, with a focus on Black women with breast cancer.